Search research articles
Contact Us
Filters
Showing results (191-200 of 275) with videos related to
Page
of 28
Sort By:
American Journal of Hematology
|
October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia
Yishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
American Journal of Infection Control
|
November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial
Ilana Oren, Hannah Sprecher, Renato Finkelstein, et al.
Blood
|
August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood Advances
|
November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Tsila Zuckerman, Ron Ram, Luiza Akria, et al.
Nature Medicine
|
February 5, 2013
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Gannie Tzoneva, Arianne Perez-Garcia, Zachary Carpenter, et al.
Leukemia Research
|
March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129
Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.
The Journal of Experimental Medicine
|
December 14, 2011
ETV6 mutations in early immature human T cell leukemias
Pieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.
Blood
|
August 3, 2013
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Arianne Perez-Garcia, Alberto Ambesi-Impiombato, Michael Hadler, et al.
Blood
|
November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Adele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Leukemia & Lymphoma
|
May 19, 2020
Venetoclax is safe and efficacious in relapsed/refractory AML
Chezi Ganzel, Ron Ram, Alexander Gural, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 275) with videos related to
Sort By:
Page
of 28
American Journal of Hematology
|
October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia
Yishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
American Journal of Infection Control
|
November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial
Ilana Oren, Hannah Sprecher, Renato Finkelstein, et al.
Blood
|
August 18, 2005
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
Jacob M Rowe, Georgina Buck, Alan K Burnett, et al.
Blood Advances
|
November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study
Tsila Zuckerman, Ron Ram, Luiza Akria, et al.
Nature Medicine
|
February 5, 2013
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Gannie Tzoneva, Arianne Perez-Garcia, Zachary Carpenter, et al.
Leukemia Research
|
March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129
Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.
The Journal of Experimental Medicine
|
December 14, 2011
ETV6 mutations in early immature human T cell leukemias
Pieter Van Vlierberghe, Alberto Ambesi-Impiombato, Arianne Perez-Garcia, et al.
Blood
|
August 3, 2013
Genetic loss of SH2B3 in acute lymphoblastic leukemia
Arianne Perez-Garcia, Alberto Ambesi-Impiombato, Michael Hadler, et al.
Blood
|
November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
Adele K Fielding, Jacob M Rowe, Georgina Buck, et al.
Leukemia & Lymphoma
|
May 19, 2020
Venetoclax is safe and efficacious in relapsed/refractory AML
Chezi Ganzel, Ron Ram, Alexander Gural, et al.
Page
of 28